In patients with grade 1 BC, only high CLDN11 expression indicated better RFS, whereas high expression of CLDN3 and CLDN4 correlated with poor OS in patients with grade 2 BC, whereas a high CLDN12 expression had better OS. This evidence concerns the gene CLDN12 and breast cancer.